一种新型抗心律失常药物安搏律定的治疗效果及血药浓度 - Suppr

Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug.

作者信息

Van Durme J P, Bogaert M G, Rosseel M T

出版信息

Eur J Clin Pharmacol. 1974 Aug 23;7(5):343-6. doi: 10.1007/BF00558203.

DOI:10.1007/BF00558203

PMID:4607575

Abstract

摘要

相似文献

Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug.

Eur J Clin Pharmacol. 1974 Aug 23;7(5):343-6. doi: 10.1007/BF00558203.

[Clinical experiences with a new orally effective antiarrhythmic agent (Aprindin)].

Z Kardiol. 1974 May;63(3):435-44.

Preliminary experience in the treatment of cardiac arrhythmias with aprindine.

Acta Cardiol. 1974;Suppl 18:355-60.

[Oral antiarrhythmic longtime therapy with aprindine (AC 1802)].

Verh Dtsch Ges Inn Med. 1973;79:1001-3.

[Anti-arrhythmic efficacy of aprindine during the acute phase of myocardial infarct].

Acta Cardiol. 1974;Suppl 18:409-21.

Treatment of chronic ventricular dysrhythmias with a new drug: aprindine (AC 1802).

Acta Cardiol. 1974;Suppl 18:335-40.

[Clinical study of a new anti-arrhythmia agent: aprindine].

Acta Cardiol. 1974;Suppl 18:361-8.

[Treatment of rhythm disorders with aprindine. Results in 86 patients].

Acta Cardiol. 1974;Suppl 18:389-407.

The pharmacology and clinical evaluation of aprindine a new antiarrhythmic agent.

Acta Cardiol. 1974;Suppl 18:317-33.

[Comparison of aprindine (AC 1802) and lidocaine by intravenous route during the acute phase of myocardial infarct].

Acta Cardiol. 1974;Suppl 18:423-32.

引用本文的文献

Comparison of the therapeutic effectiveness of aprindine, procainamide and quinidine in chronic ventricular dysrhythmias.

Br J Clin Pharmacol. 1974 Dec;1(6):461-6. doi: 10.1111/j.1365-2125.1974.tb01695.x.

Binding of aprindine and moxaprindine to human serum, alpha 1-acid glycoprotein and serum of healthy and diseased humans.

Eur J Clin Pharmacol. 1982;21(5):427-31. doi: 10.1007/BF00542331.

Dose-dependent pharmacokinetics of aprindine in healthy volunteers.

Eur J Clin Pharmacol. 1984;26(1):129-31. doi: 10.1007/BF00546721.

Reliability of antiarrhythmic drug plasma concentration monitoring.

Clin Pharmacokinet. 1983 Jan-Feb;8(1):63-82. doi: 10.2165/00003088-198308010-00004.

Absorption, half-life, and toxicity of oral aprindine in patients with acute myocardial infarction.

Eur J Clin Pharmacol. 1975 Oct 10;9(1):21-5. doi: 10.1007/BF00613425.

Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.

Drugs. 1978 Apr;15(4):271-309. doi: 10.2165/00003495-197815040-00003.

本文引用的文献

New method for heart studies.

Science. 1961 Oct 20;134(3486):1214-20. doi: 10.1126/science.134.3486.1214.

Lidocaine in acute myocardial infarction.

Am Heart J. 1968 Oct;76(4):586-7. doi: 10.1016/0002-8703(68)90148-8.

Procainamide dosage schedules, plasma concentrations, and clinical effects.

JAMA. 1971 Mar 1;215(9):1454-60.

Quinidine for prophylaxis of arrhythmias in acute myocardial infarction.

N Engl J Med. 1971 Oct 28;285(18):979-86. doi: 10.1056/NEJM197110282851801.

Antiarrhythmic prophylaxis with procainamide in acute myocardial infarction.

N Engl J Med. 1969 Dec 4;281(23):1253-60. doi: 10.1056/NEJM196912042812301.

Electrophysiological effects of aprindine on isolated heart preparations.

Eur J Pharmacol. 1974 May;26(2):338-47. doi: 10.1016/0014-2999(74)90245-3.

Editorial: Pharmacokinetics--master or servant?

Eur J Clin Pharmacol. 1973 Jun;6(1):1-2. doi: 10.1007/BF00561792.

Clinical use of blood levels of cardiac drugs.

Mod Concepts Cardiovasc Dis. 1973 Jan;42(1):1-4.

Pharmacological evaluation of aprindine (AC 1802) a new antiarrhythmic agent.

Acta Cardiol. 1973;28(2):166-91.

Treatment of chronic ventricular dysrhythmias with a new drug: aprindine (AC 1802).

Acta Cardiol. 1974;Suppl 18:335-40.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献